摘要
嗜黏蛋白阿克曼菌(Akkermansia muciniphila,AKK)作为近年来研究的下一代益生菌,具有广泛的应用前景,研究表明其可以改善包括脂肪肝、肥胖在内的代谢疾病和炎症性肠病等多种疾病。然而,对AKK的研究主要集中在人与模型动物上,而在畜禽方面的研究仍不够深入,本文综述了近年来AKK在脂肪肝病、肥胖、糖尿病等代谢性疾病以及肠道疾病方面的研究,为推进AKK在畜禽代谢紊乱、肠道疾病中的研究及应用提供参考。
Akkermansia muciniphila(A.muciniphila)as the next generation probiotics studied in recent years,has a wide range of application prospects.Studies have shown that A.muciniphila can improve diseases inclu-ding fatty liver,obesity and inflammatory bowel disease.However,the research on A.muciniphila mainly fo-cuses on humans and model animals,while the research on livestock and poultry is still not in-depth enough,this paper focus on the mechanism of A.muciniphila in recent years in metabolic diseases such as fatty liver dis-ease,obesity,diabetes,intestinal barrier destruction and intestinal inflammation,aiming to promote the re-search and application of A.muciniphila in livestock and poultry production metabolic disorders and intestinal diseases to provide reference.
作者
王祥煌
杜雯鹃
徐乐
许庆彪
WANG Xianghuang;DU Wenjuan;XU Le;XU Qingbiao(College of Animal Science and Technology,Huazhong Agricultural University,Wuhan 430070,China)
出处
《动物营养学报》
CAS
CSCD
北大核心
2023年第9期5598-5610,共13页
CHINESE JOURNAL OF ANIMAL NUTRITION
基金
十四五国家重点研发计划(2022YFD1301004,2022YFD1300705)
安徽省自然科学基金项目(2008085MC86)。
关键词
噬黏蛋白阿克曼菌
糖代谢
脂质代谢
肠道屏障
肠道炎症
Akkermansia muciniphila
glycometabolism
lipid metabolism
intestinal barrier
intestinal in-flammation